Previous studies reported that administration of recombinant HGF mitigated alcohol-induced liver damage, ischemia-reperfusion liver injury, endotoxin-induced fulminant hepatitis, and liver fibrosis (8–12). The gene discussed is HGF; the disease is Hepatic fibrosis.